Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q2 2026 (June 30)14holders −2
2new positions
4sold out
1famous investor
$0.86avg. 13F price*
At the end of Q2 2026, 14 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, down 2 from Q1 2026. 2 opened new positions and 4 sold out. The largest holders were Yorkville Advisors Global, LP ($107K), Gagnon Securities LLC ($75K) and Citadel Advisors ($55K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $13K |
| Exits | 4 | $32K |
All 13F filers, Q1 2026 → Q2 2026: 69,308 shares bought and 272,147 shares sold, net −202,839 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Yorkville Advisors Global, LP | 0.12% | Reduce -65.2% | 122,131 | $107K |
| Gagnon Securities LLC | 0.01% | No change | 88,405 | $75K |
| Citadel Advisors | 0.00% | Add +216.0% | 65,321 | $55K |
| Rhumbline Advisers | 0.00% | Add +168.9% | 13,755 | $12K |
| Lido Advisors, LLC | 0.00% | New | 11,009 | $9K |
| GAMMA Investing LLC | 0.00% | Add +4.1% | 6,957 | $6K |
| Citigroup Inc. | 0.00% | New | 4,378 | $4K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 3,388 | $3K |
| UBS Group AG | 0.00% | Reduce -87.9% | 100 | $85 |
| SBI Securities Co., Ltd. | 0.00% | Add +275.0% | 15 | $13 |
| Smartleaf Asset Management LLC | 0.00% | No change | 5 | $4 |
| Vermillion Wealth Management, Inc. | 0.00% | No change | 2 | $2 |
| Morgan Stanley | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | Add +35000.0% | 351 | $0 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.